Facebook
Twitter
ВКонтакте
Telegram
Сообщить о неточностиКвартальный отчет 2023-Q3
добавлен 09.11.2023
NeuBase Therapeutics Мультипликаторы 2011-2024 | NBSE
Мультипликаторы по годам NeuBase Therapeutics
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
P/E |
- | -1.1 | -8.8 | -1.6 | -0.9 | -1.1 | -3.8 | -5.5 | -17.4 | -23.8 | -46.7 | -4.9 |
P/S |
- | -121.6 | - | - | - | - | - | - | - | - | - | - |
EPS |
-1.0 | -0.9 | -0.9 | -3.3 | -0.2 | -0.5 | -0.8 | -0.5 | -0.4 | -0.3 | -0.0 | -0.1 |
EV (Enterprise Value) |
-13.7 млн | -15.5 млн | 125 млн | 35 млн | 12.3 млн | 19.6 млн | 89.1 млн | 58.4 млн | 151 млн | 130 млн | 66.4 млн | 30.9 млн |
EBITDA per Share |
-1 | -0.96 | -0.856 | -3.17 | -2.82 | -10.1 | -15.4 | -11.5 | -7.82 | -4.84 | -4.49 | -1.8 |
EV/EBITDA |
0.6 | -7.3 | -1.2 | -1.0 | -0.6 | -3.5 | -3.4 | -16.8 | -28.6 | -20.4 | -21.3 | |
PEG |
- | 0.03 | -0.12 | -0.05 | -0.02 | -0.03 | 0.07 | 0.17 | 0.47 | 0.1 | -0.61 | 0.01 |
P/B |
- | 0.5 | 4.9 | 4.3 | 1.1 | 1.2 | 3.9 | 2.0 | 5.9 | 25.6 | 28.0 | -5.3 |
P/CF |
- | -1.4 | -13.5 | -12.6 | -1.2 | -1.4 | -6.1 | -7.7 | -17.9 | -50.0 | -38.0 | -25.0 |
ROE % |
-145.64 | -46.99 | -55.55 | -268.79 | -121.43 | -104.23 | -103.22 | -35.77 | -34.13 | -107.38 | -59.96 | 106.69 |
ROA % |
-103.31 | -39.60 | -50.47 | -215.13 | -113.85 | -85.26 | -87.51 | -32.77 | -28.51 | -98.41 | -41.36 | -361.08 |
ROCE % |
-143.66 | -49.13 | -54.54 | -262.59 | -83.28 | -103.72 | -101.37 | -41.11 | -34.10 | -87.78 | -135.45 | 26.00 |
Current Ratio |
3.4 | 6.4 | 10.4 | 4.4 | 5.5 | 2.6 | 3.0 | 7.5 | 2.5 | 10.8 | 2.6 | 0.1 |
DSO |
- | - | - | - | - | - | - | - | - | - | - | - |
DIO |
- | - | - | - | - | - | - | - | - | - | - | - |
DPO |
- | - | - | - | - | - | - | - | - | - | - | - |
Операционный цикл |
- | - | - | - | - | - | - | - | - | - | - | - |
Финансовый цикл |
- | - | - | - | - | - | - | - | - | - | - | - |
Все данные представлены в валюте USD
Мультипликаторы поквартально NeuBase Therapeutics
| 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
EPS |
-0.66 | -2.04 | -0.12 | -0.13 | -4.73 | -5.26 | -0.3 | -0.24 | -0.72 | -0.29 | -0.24 | -0.18 | -0.69 | -0.18 | -0.26 | -0.26 | -0.96 | -0.38 | -0.26 | -0.25 | -3.36 | -0.19 | -0.32 | -1.48 | -0.45 | -0.07 | -0.07 | -0.21 | -0.21 | -0.24 | -0.21 | -0.2 | -0.13 | -0.11 | -0.2 | -0.18 | -0.12 | -0.09 | -0.18 | -0.1 | -0.07 | -0.07 | -0.1 | -0.14 | -0.11 | -0.03 | -0.05 | 0.01 | -0.1 | -0.08 | - |
EBITDA per Share |
-0.98 | -2.06 | -0.12 | -2.66 | -4.66 | -5.06 | -0.3 | -0.22 | -0.75 | -0.29 | -0.25 | -0.2 | -0.64 | -0.17 | -0.27 | -0.21 | -0.93 | -0.34 | -0.21 | -0.25 | -3.27 | -0.31 | -0.26 | -1.39 | -0.43 | -0.07 | -0.07 | -0.2 | -0.18 | -0.23 | -0.2 | -0.11 | -0.08 | -0.1 | -0.11 | -0.15 | -0.14 | -0.08 | -0.15 | -0.1 | -0.11 | -0.07 | -0.1 | -0.02 | -0.15 | -0.04 | -0.02 | -0.01 | -0.02 | -0.01 | -0.01 |
ROE % |
-102.88 | -115.86 | -113.23 | -110.90 | -103.32 | -104.17 | -90.53 | -87.59 | -85.45 | -92.23 | -91.18 | -82.37 | -132.22 | -147.06 | -162.68 | -212.53 | 230.81 | 277.27 | 297.31 | 352.51 | -47.81 | -120.18 | -128.35 | -140.53 | -146.43 | -91.74 | -105.51 | -112.37 | -101.18 | -83.80 | -60.83 | -47.35 | -51.63 | -53.97 | -53.77 | -56.49 | -83.00 | -105.72 | -123.47 | -144.69 | -508.73 | -537.21 | -530.78 | -583.80 | -183.33 | -42.30 | 42.30 | 126.40 | 78.28 | 65.62 | -7.33 |
ROA % |
-61.36 | -74.93 | -80.73 | -81.99 | -78.46 | -83.56 | -74.82 | -63.09 | -62.76 | -71.15 | -69.68 | -72.88 | -105.28 | -112.76 | -117.97 | -142.12 | -1181.48 | -1496.80 | -1488.28 | -1460.74 | -393.47 | -100.32 | -106.57 | -113.03 | -118.77 | -74.83 | -87.02 | -95.84 | -86.30 | -72.19 | -53.26 | -42.82 | -44.36 | -45.57 | -44.76 | -45.86 | -74.47 | -96.22 | -113.12 | -133.96 | -165.77 | -177.65 | -167.45 | -195.31 | -102.53 | -324.19 | -533.17 | -445.28 | -264.94 | -222.07 | 24.82 |
ROCE % |
-50.49 | -83.79 | -86.13 | -112.15 | -102.40 | -104.97 | -92.05 | -90.66 | -91.51 | -93.86 | -92.61 | -84.32 | -121.80 | -137.23 | -151.72 | -189.19 | 240.14 | 220.85 | 237.17 | 281.99 | -114.76 | -122.89 | -128.20 | -140.45 | -146.20 | -92.40 | -105.96 | -112.66 | -94.90 | -75.76 | -53.17 | -33.68 | -43.05 | -46.41 | -46.24 | -52.46 | -80.45 | -103.19 | -120.87 | -144.60 | -248.83 | -298.65 | -299.43 | -294.61 | -129.39 | -27.19 | -378.20 | -334.22 | 18.15 | -377.17 | 10.40 |
Current Ratio |
2.0 | 2.0 | 3.1 | 3.5 | 3.4 | 4.1 | 4.6 | 5.8 | 6.3 | 7.7 | 6.3 | 13.7 | 10.9 | 10.9 | 10.9 | 3.5 | 5.0 | 5.0 | 5.0 | 0.3 | 0.9 | 16.0 | 17.9 | 6.2 | 5.5 | 5.5 | 5.5 | 7.7 | 6.6 | 6.6 | 6.6 | 8.4 | 11.9 | 11.9 | 11.9 | 4.3 | 6.1 | 6.1 | 6.1 | 18.3 | 12.0 | 12.0 | 12.0 | 1.2 | 3.2 | 3.2 | 3.2 | 0.4 | 0.2 | 0.2 | 0.2 |
DSO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DIO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DPO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Операционный цикл |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Финансовый цикл |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Все данные представлены в валюте USD